Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling.
Schizophrenia is a complex disorder that interferes with the function of several brain systems required for cognition and normal social behaviour. Although the most notable clinical aspects of the disease only become apparent during late adolescence or early adulthood, many lines of evidence suggest that schizophrenia is a neurodevelopmental disorder with a strong genetic component. Several independent studies have identified neuregulin 1 (NRG1) and its receptor ERBB4 as important risk genes for schizophrenia, although their precise role in the disease process remains unknown. Here we show that Nrg1 and ErbB4 signalling controls the development of inhibitory circuitries in the mammalian cerebral cortex by cell-autonomously regulating the connectivity of specific GABA (gamma-aminobutyric acid)-containing interneurons. In contrast to the prevalent view, which supports a role for these genes in the formation and function of excitatory synapses between pyramidal cells, we found that ErbB4 expression in the mouse neocortex and hippocampus is largely confined to certain classes of interneurons. In particular, ErbB4 is expressed by many parvalbumin-expressing chandelier and basket cells, where it localizes to axon terminals and postsynaptic densities receiving glutamatergic input. Gain- and loss-of-function experiments, both in vitro and in vivo, demonstrate that ErbB4 cell-autonomously promotes the formation of axo-axonic inhibitory synapses over pyramidal cells, and that this function is probably mediated by Nrg1. In addition, ErbB4 expression in GABA-containing interneurons regulates the formation of excitatory synapses onto the dendrites of these cells. By contrast, ErbB4 is dispensable for excitatory transmission between pyramidal neurons. Altogether, our results indicate that Nrg1 and ErbB4 signalling is required for the wiring of GABA-mediated circuits in the postnatal cortex, providing a new perspective to the involvement of these genes in the aetiology of schizophrenia.
Fazzari
Pietro
P
Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas & Universidad Miguel Hernández, 03550 Sant Joan d'Alacant, Spain.
Paternain
Ana V
AV
Valiente
Manuel
M
Pla
Ramón
R
Luján
Rafael
R
Lloyd
Kent
K
Lerma
Juan
J
Marín
Oscar
O
Rico
Beatriz
B
D000818:Animals; D002454:Cell Differentiation; D002540:Cerebral Cortex / Q000166:cytology / Q000196:embryology / Q000254:growth & development / Q000378:metabolism*; D003712:Dendrites / Q000378:metabolism; D004622:Embryo, Mammalian; D066246:ErbB Receptors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D019706:Excitatory Postsynaptic Potentials / Q000235:genetics / Q000502:physiology; D005260:Female; D066298:In Vitro Techniques; D007395:Interneurons / Q000378:metabolism*; D051379:Mice; D009433:Neural Inhibition / Q000235:genetics / Q000502:physiology; D009434:Neural Pathways / Q000502:physiology*; D020890:Neuregulin-1 / Q000378:metabolism*; D017966:Pyramidal Cells / Q000378:metabolism; D066247:Receptor, ErbB-4; D012559:Schizophrenia / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D013569:Synapses / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D020890:Neuregulin-1; C490581:Nrg1 protein, mouse; D005680:gamma-Aminobutyric Acid; D066246:ErbB Receptors; C587690:Erbb4 protein, mouse; D066247:Receptor, ErbB-4
Trends Neurosci. 2007 Jul;30(7):317-24
17499860
Nat Neurosci. 2006 Dec;9(12):1477-8
17072305
J Neurosci. 2006 Jun 28;26(26):6924-34
16807322
Cereb Cortex. 2004 Oct;14(10):1122-33
15115742
Science. 2008 Jul 4;321(5885):53-7
18599766
Neuron. 2007 Feb 15;53(4):591-604
17296559
J Neurosci. 2003 Aug 13;23(19):7407-11
12917376
J Neurosci. 2004 Oct 13;24(41):8986-93
15483117
Nat Rev Neurosci. 2008 Jun;9(6):437-52
18478032
Neuron. 2000 May;26(2):443-55
10839362
Brain Res. 1977 May 13;126(3):397-42
861729
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4507-12
19240213
Nature. 1995 Nov 23;378(6555):390-4
7477376
Neuron. 2007 May 24;54(4):599-610
17521572
Nat Rev Neurosci. 2006 Sep;7(9):687-96
16883309
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5341-6
9560277
Brain Res Bull. 2007 Jul 12;73(4-6):210-9
17562386
J Neurosci. 2009 Sep 30;29(39):12255-64
19793984
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3596-601
10725395
Neuron. 2004 Oct 14;44(2):251-61
15473965
Nat Rev Neurosci. 2004 Oct;5(10):793-807
15378039
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8281-6
12824469
Nature. 2006 Aug 24;442(7105):929-33
16906136
Mol Psychiatry. 2004 Jan;9(1):14-27
14581932
Neuroscience. 1982;7(11):2577-607
7155343
J Neurosci. 2005 Oct 12;25(41):9378-83
16221846
Eur J Neurosci. 1996 Jul;8(7):1488-500
8758956
Genesis. 2006 Dec;44(12):611-21
17146780
J Neurosci. 2007 Apr 25;27(17):4519-29
17460065
J Physiol. 1997 May 1;500 ( Pt 3):715-38
9161987
Behav Brain Res. 2004 Aug 12;153(1):159-70
15219717
Annu Rev Neurosci. 2002;25:409-32
12052915
J Neurosci. 2003 Jan 1;23(1):167-74
12514213
Nature. 2009 Jun 4;459(7247):663-7
19396156
Nat Rev Neurosci. 2005 Apr;6(4):312-24
15803162
Mol Psychiatry. 2007 Feb;12(2):195-205
17033632
Neuron. 2007 May 24;54(4):583-97
17521571
J Neurosci. 1999 Nov 15;19(22):10082-97
10559416
EMBO J. 1995 Dec 1;14(23):5842-8
8846777
Nature. 2009 Jun 4;459(7247):698-702
19396159
J Biol Chem. 2008 Nov 21;283(47):32944-56
18819924
Am J Hum Genet. 2002 Oct;71(4):877-92
12145742